Copertina

Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction‐associated steatotic liver disease

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Nabil Noureddin, Daniel Q. Huang, Ricki Bettencourt, Harris Siddiqi, Abdul M. Majzoub, Tarek Nayfeh, Nobuharu Tamaki, Namiki Izumi, Atsushi Nakajima, Ramazan Idilman, Mesut Gumussoy, Digdem Kuru Oz, Ayse Erden, Tolga Gidener, Alina M. Allen, Veeral Ajmera, Rohit Loomba
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Alimentary Pharmacology & Therapeutics
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

A prospective study on the prevalence of at‐risk MASH in patients with type 2 diabetes mellitus in the United States
di: Nikita Mittal, et al.
Pubblicazione: (2024)

Cardiometabolic criteria as predictors and treatment targets of liver‐related events and cardiovascular events in metabolic dysfunction‐associated steatotic liver disease
di: Nobuharu Tamaki, et al.
Pubblicazione: (2024)

Long‐term clinical outcomes in steatotic liver disease and incidence of liver‐related events, cardiovascular events and all‐cause mortality
di: Nobuharu Tamaki, et al.
Pubblicazione: (2024)

The impact of genetic risk on the prevalence of advanced fibrosis and cirrhosis in prospectively assessed patients with type 2 diabetes
di: Lana Bridi, et al.
Pubblicazione: (2024)

Gastrointestinal Cancer Risk in Steatotic Liver Diseases: MASLD , MetALD and ALD
di: Nobuharu Tamaki, et al.
Pubblicazione: (2025)

Editorial: Genetics for non‐invasive risk stratification—Finding the needle in the haystack? Authors' reply
di: Lana Bridi, et al.
Pubblicazione: (2024)

Editorial: Steatotic Liver Diseases Emerge as Rapidly Growing Drivers of Primary Liver Cancer in the United States
di: Kelly Torosian, et al.
Pubblicazione: (2025)

Glycemic control target for liver and cardiovascular events risk in metabolic dysfunction‐associated steatotic liver disease
di: Nobuharu Tamaki, et al.
Pubblicazione: (2024)

Head‐to‐Head Comparison Between Phosphatidylethanol Versus Indirect Alcohol Biomarkers for Diagnosis of MetALD Versus MASLD: A Prospective Study
di: Federica Tavaglione, et al.
Pubblicazione: (2025)

Editorial: Comparable Hepatic Fibrosis Risk Demands Equal Vigilance in Lean and Non‐Lean Patients With Metabolic Dysfunction‐Associated Steatotic Liver Disease—Authors' Reply
di: Kaleb Tesfai, et al.
Pubblicazione: (2025)

Letter on ‘Inherited Genetic Risk of Liver Fibrosis in Lean Versus Nonlean Metabolic Dysfunction‐Associated Steatotic Liver Disease ( MASLD )’; Authors’ reply
di: Kaleb Tesfai, et al.
Pubblicazione: (2026)

Repeatability of vibration‐controlled transient elastography versus magnetic resonance elastography in patients with cirrhosis: A prospective study
di: Harris Siddiqi, et al.
Pubblicazione: (2024)

A Prospective Study on the Prevalence of MASLD in Patients With Type 2 Diabetes and Hyperferritinaemia
di: Maral Amangurbanova, et al.
Pubblicazione: (2024)

Clinical Trial: Semaglutide Versus Placebo in NIT ‐Assessed MASH —A Multicenter Randomised Placebo‐Controlled Trial ( SAMARA )
di: Veeral Ajmera, et al.
Pubblicazione: (2026)

Editorial: Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral‐Induced Cure of Hepatitis C Virus Infection
di: Nobuharu Tamaki, et al.
Pubblicazione: (2025)

Editorial: Crystalising the burden of steatotic liver disease—Authors' reply
di: Carolin V. Schneider, et al.
Pubblicazione: (2024)

Retreatment of Direct Acting Agents (DAAs) After Initial DAA Failure in Hepatitis C Patients
di: Nobuharu Tamaki, et al.
Pubblicazione: (2026)

Editorial: Updated epidemiology of steatotic liver disease in people withHIVin the United States—Authors' reply
di: Samer Gawrieh, et al.
Pubblicazione: (2024)

An $\mathcal{O}(n)$ Space Construction of Superpermutations
di: Ajmera, Dhruv
Pubblicazione: (2025)

Editorial: M et ALD and Risk of Gastrointestinal Cancer—What Can We Learn From Japan? Authors' Reply
di: Nobuharu Tamaki, et al.
Pubblicazione: (2025)

Psychosocial predictors of return to alcohol use after liver transplant: A multicenter cohort study
di: Kelly Torosian, et al.
Pubblicazione: (2024)

Prevalence of at‐risk MASH, MetALD and alcohol‐associated steatotic liver disease in the general population
di: Carolin V. Schneider, et al.
Pubblicazione: (2024)

National Report of Teachers' Experiences with School Justifications for Book Censorship
di: Ricki Ginsberg, et al.
Pubblicazione: (2025)

National Report of Teachers' Experiences With School Justifications for Book Censorship
di: Ricki Ginsberg, et al.
Pubblicazione: (2025)

On the connection between weak measurement in quantum physics and analytic phase-retrieval in classical wave optics
di: Nakajima, Nobuharu
Pubblicazione: (2023)

Ezop Alla Turca: Tanzimat Öncesi Döneme Ait Ezop Tercümelerinin Kültürel Çeviri Bağlamında İncelenmesi
di: Kuru, Mehmet
Pubblicazione: (2022)

Reconfigurable qubit states and quantum trajectories in a synthetic artificial neuron network with a process to direct information generation from co-integrated burst-mode spiking under non-Markovianity
di: Nayfeh, Osama M., et al.
Pubblicazione: (2025)

Strong convergence of a resolution of the identity via canonical coherent states
di: Namiki, Ryo
Pubblicazione: (2024)

Assessing the Psychosocial Impact of Acne Scars on Individuals With Pigmented Skin: A Multicenter Observational Study
di: Marwa Majzoub, et al.
Pubblicazione: (2025)

Dynamic Rank Reinforcement Learning for Adaptive Low-Rank Multi-Head Self Attention in Large Language Models
di: Erden, Caner
Pubblicazione: (2025)

Multiscale Aggregated Hierarchical Attention (MAHA): A Game Theoretic and Optimization Driven Approach to Efficient Contextual Modeling in Large Language Models
di: Erden, Caner
Pubblicazione: (2025)

Learning Emergence of Interaction Patterns across Independent RL Agents in Multi-Agent Environments
di: Baddam, Vasanth Reddy, et al.
Pubblicazione: (2024)

Effects of Resmetirom on Metabolic‐Dysfunction Associated Steatohepatitis in Patients With Weight Loss and/or Diabetes Taking Glucagon‐Like Peptide‐1 Receptor Agonists and Other Diabetes Therapies: A Secondary Analysis of the MAESTRO ‐ NASH Trial
di: Mazen Noureddin, et al.
Pubblicazione: (2025)

Significados das avaliações do ensino pelos estudantes: um estudo qualitativo na educação superior brasileira
di: Maria Beatriz Bettencourt
Pubblicazione: (2017)

Palmitoylcarnitine impairs immunity in decompensated cirrhosis
di: Wei Zhang, Ingrid, et al.
Pubblicazione: (2024)

Influence of further decompensation on survival across clinical stages of decompensated cirrhosis: The role of portal hypertension and HVPG changes
di: Marta Garcia‐Guix, et al.
Pubblicazione: (2024)

Evolution, Future of AI, and Singularity
di: Erden, Zeki Doruk
Pubblicazione: (2025)

Co‐Expression of Chaperones for Improvement of Recombinant Geobacillus stearothermophilus Lipase Production in Pichia pastoris
di: Fidan Erden‐Karaoglan
Pubblicazione: (2025)

Certifying Stability and Performance of Uncertain Differential-Algebraic Systems: A Dissipativity Framework
di: Jensen, Emily, et al.
Pubblicazione: (2023)

Grouping of $N-1$ Contingencies for Controller Synthesis: A Study for Power Line Failures
di: Junnarkar, Neelay, et al.
Pubblicazione: (2024)